Shigenori E. Nagai

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

Yasuhiro Fujiwara, Hirofumi Mukai, Toshiaki Saeki et al. · British Journal of Cancer · 2019 · 123 citations · Full text

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition

Tomohiko Aihara, Tatsuya Toyama, Masato Takahashi et al. · Breast Cancer · 2016 · 88 citations · Full text

Nursing, Surgical Oncology, Breast Oncology +8

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

Tatsunori Shimoi, Shigenori E. Nagai, Tetsuhiro Yoshinami et al. · Breast Cancer · 2020 · 75 citations · Full text

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

Yuji Hayashi, Hiroyuki Takei, Satoshi Nozu et al. · Oncology Letters · 2012 · 65 citations · Full text

Pathological Tumor Responses, Breast Oncology, Neoadjuvant Chemotherapy +12

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

Mitsuo Terada, Aki Ito, Yuichiro Kikawa et al. · Breast Cancer · 2023 · 53 citations · Full text